Literature DB >> 21901305

Should newborns be screened for immunodeficiency?: lessons learned from infants with recurrent otitis media.

Yesim Yilmaz-Demirdag1.   

Abstract

Recurrent otitis media in children is considered one of the warning signs of primary immunodeficiencies (PIDs), particularly antibody deficiencies. Infants who have the most serious and potentially lethal form of PID, severe combined immunodeficiency (SCID), sometimes present with recurrent otitis media. Most of the time, because of the severity of the immune defect, they develop more serious and systemic infections. SCID is distinct among the PIDs and considered a pediatric emergency. Diagnosing SCID during the newborn period is crucial because survival completely depends on early diagnosis and treatment. Mortality declines significantly if immune reconstitution is established before 3.5 months of age, particularly before severe infections have occurred. However, most patients are diagnosed after they have suffered chronic or recurrent infections and developed permanent sequelae. Without institution of population-based newborn screening, most infants will miss the opportunity to live a healthy life.

Entities:  

Mesh:

Year:  2011        PMID: 21901305     DOI: 10.1007/s11882-011-0221-8

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  54 in total

1.  Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening.

Authors:  Lucinda Brown; Jinhua Xu-Bayford; Zoe Allwood; Mary Slatter; Andrew Cant; E Graham Davies; Paul Veys; Andrew R Gennery; H Bobby Gaspar
Journal:  Blood       Date:  2011-01-27       Impact factor: 22.113

Review 2.  Multi-tasking of helper T cells.

Authors:  Yisong Y Wan
Journal:  Immunology       Date:  2010-06       Impact factor: 7.397

3.  Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease.

Authors:  C Kung; J T Pingel; M Heikinheimo; T Klemola; K Varkila; L I Yoo; K Vuopala; M Poyhonen; M Uhari; M Rogers; S H Speck; T Chatila; M L Thomas
Journal:  Nat Med       Date:  2000-03       Impact factor: 53.440

4.  Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric medicaid population.

Authors:  S Berman; P J Byrns; J Bondy; P J Smith; D Lezotte
Journal:  Pediatrics       Date:  1997-10       Impact factor: 7.124

5.  Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study.

Authors:  D W Teele; J O Klein; B Rosner
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

6.  Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency.

Authors:  D Moshous; I Callebaut; R de Chasseval; B Corneo; M Cavazzana-Calvo; F Le Deist; I Tezcan; O Sanal; Y Bertrand; N Philippe; A Fischer; J P de Villartay
Journal:  Cell       Date:  2001-04-20       Impact factor: 41.582

Review 7.  Allergic rhinitis, histamine, and otitis media.

Authors:  Amanda R Skoner; Kelleen R Skoner; David P Skoner
Journal:  Allergy Asthma Proc       Date:  2009 Sep-Oct       Impact factor: 2.587

8.  Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis.

Authors:  Mary Dell Railey; Yuliya Lokhnygina; Rebecca H Buckley
Journal:  J Pediatr       Date:  2009-10-09       Impact factor: 4.406

Review 9.  Ambulatory health care visits by children: principal diagnosis and place of visit.

Authors:  V M Freid; D M Makuc; R N Rooks
Journal:  Vital Health Stat 13       Date:  1998-05

Review 10.  Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways.

Authors:  Panu E Kovanen; Warren J Leonard
Journal:  Immunol Rev       Date:  2004-12       Impact factor: 12.988

View more
  1 in total

1.  Clinical predictors of primary immunodeficiency diseases in children.

Authors:  Shereen M Reda; Dalia H El-Ghoneimy; Hanaa M Afifi
Journal:  Allergy Asthma Immunol Res       Date:  2012-11-02       Impact factor: 5.764

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.